Omega-7 (Palmitoleic Acid) 用于 动脉粥样硬化
D 研究 目前仅存在初步研究(实验室研究、病例报告)。Cleveland Clinic study showed CRP reduction (an inflammatory marker associated with atherosclerosis) but no direct imaging endpoints. Very limited evidence.
结论
Cleveland Clinic study showed CRP reduction (an inflammatory marker associated with atherosclerosis) but no direct imaging endpoints. Very limited evidence.
Key Statistics
1
研究数量
60
受试者
Positive
等级
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 210-420 mg/day purified palmitoleic acid
上限: Not formally established
最佳服用时间: With meals
Safety & Side Effects
已报告的副作用
- ⚠ Mild gastrointestinal discomfort
- ⚠ May interact with blood-thinning medications at high doses
已知相互作用
- ● Anticoagulants (theoretical additive effect)
- ● Lipid-lowering medications (may have additive effects)
可耐受最高摄入量: Not formally established
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Omega-7 (Palmitoleic Acid) help with 动脉粥样硬化?
How much Omega-7 (Palmitoleic Acid) should I take for 动脉粥样硬化?
Are there side effects of Omega-7 (Palmitoleic Acid)?
How strong is the evidence for Omega-7 (Palmitoleic Acid) and 动脉粥样硬化?
Related Evidence
其他成分用于 动脉粥样硬化
Omega-7 (Palmitoleic Acid) 用于其他健康状况
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。